×
Masimo Inventory 2010-2025 | MASI
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Masimo inventory for the quarter ending March 31, 2025 was
$0.301B
, a
40.49% decline
year-over-year.
Masimo inventory for 2024 was
$0.459B
, a
15.74% decline
from 2023.
Masimo inventory for 2023 was
$0.545B
, a
8.78% increase
from 2022.
Masimo inventory for 2022 was
$0.501B
, a
148.76% increase
from 2021.
View More
Masimo Inventory 2010-2025 | MASI
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Masimo inventory for 2024 was
$0.459B
, a
15.74% decline
from 2023.
Masimo inventory for 2023 was
$0.545B
, a
8.78% increase
from 2022.
Masimo inventory for 2022 was
$0.501B
, a
148.76% increase
from 2021.
Related Stocks
Company Name
Market
Cap
Intuitive Surgical (ISRG)
$171.9B
Thermo Fisher Scientific (TMO)
$161.4B
Alcon (ALC)
$45.6B
Edwards Lifesciences (EW)
$42B
IDEXX Laboratories (IDXX)
$33.3B
DexCom (DXCM)
$26.9B
IQVIA Holdings (IQV)
$25.4B
STERIS (STE)
$21.8B
Mettler-Toledo (MTD)
$20.9B
Waters (WAT)
$19.1B
SONOVA HOLDING (SONVY)
$17.3B
Fresenius Medical Care AG KGaA (FMS)
$13.9B
Hologic (HOLX)
$12.9B
Sysmex ADR (SSMXY)
$11.8B
Penumbra (PEN)
$10.7B
Globus Medical (GMED)
$9.8B
Teleflex (TFX)
$6B
Glaukos (GKOS)
$5.2B
Integer Holdings (ITGR)
$4.1B
TransMedics (TMDX)
$3B
PROCEPT BioRobotics (PRCT)
$2.9B
Veracyte (VCYT)
$2.4B
Nihon Kohden (NHNKY)
$2.1B
LivaNova (LIVN)
$1.9B
Elekta AB (EKTAY)
$1.9B
Alphatec Holdings (ATEC)
$1.5B
Integra LifeSciences Holdings (IART)
$1.2B
Pulse Biosciences (PLSE)
$1.2B
Tandem Diabetes Care (TNDM)
$1.1B
Paragon 28 (FNA)
$1.1B